Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of drug resistance in Mycoplasma pneumoniae.

Current drug targets. Infectious disorders - 1 Sept 2005

Bébéar C M, Pereyre S

Abstract excerpt

Mycoplasma pneumoniae is a pathogenic mycoplasma responsible for respiratory tract infections in humans, occurring worldwide in children and adults. This review briefly focuses on its antibiotic susceptibility profile and on the development of acquired resistance for this microorganism. The lack of a cell wall in mycoplasmas makes them intrinsically resistant to beta-lactams and to all antimicrobials which target...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Child
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Erythromycin

Share to Fluoroquinolones

Share to Mycoplasma pneumoniae

Share to Respiratory Tract Infections

Share to Tetracyclines

Source

Identifiers

PMID: 16181145
DOI: 10.2174/1568005054880109

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of drug resistance in Mycoplasma pneumoniae.PMID 16181145Read ↗

<i>Mycoplasma Pneumoniae</i> : Susceptibility and Resistance To AntibioticsSemantic proximity Read ↗

Evolution and characteristics of tetracycline resistance in Mycoplasma pneumoniaeSemantic proximity Read ↗

Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniaeSemantic proximity Read ↗

Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications.Semantic proximity Read ↗

Drug Resistance Mechanisms of<i>Mycoplasma pneumoniae</i>to Macrolide AntibioticsSemantic proximity Read ↗

Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.Semantic proximity Read ↗

Antimicrobial susceptibility and genotyping of Mycoplasma pneumoniae isolates in Beijing, China, from 2014 to 2016Semantic proximity Read ↗

Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.Semantic proximity Read ↗

Molecular detection and evaluation of resistance of Mycoplasma Pneumoniae to macrolide (Erythromycin) due to mutation in the 23S rRNA gene among Iranian Patients with respiratory infectionsSemantic proximity Read ↗

The reduced prevalence of macrolide resistance in <i>Mycoplasma pneumoniae</i> clinical isolates from pediatric patients in Beijing in 2016Semantic proximity Read ↗

Molecular insights into macrolide resistant Mycoplasma pneumoniae isolates from outpatient clinics in Tehran, Iran.Semantic proximity Read ↗

Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.